Last reviewed · How we verify

NCT04974177

A Study to Determine the Role of Physician Gestalt in Predicting COVID-19 in Patients

Completed Last updated 13 March 2024
What this trial tests

trial in All Patients Undergoing COVID 19 Specific Testing in 876 participants. Completed in 15 September 2022.

Timeline
15 March 2021
Primary endpoint
15 September 2022
15 September 2022

Quick facts

Lead sponsorJubilee Mission Medical College and Research Institute
StatusCompleted
Study typeOBSERVATIONAL
Enrollment876
Start date15 March 2021
Primary completion15 September 2022
Estimated completion15 September 2022
Sites1 location across India

Conditions studied

Sponsor

Jubilee Mission Medical College and Research Institute

Who can join

Eligibility, any sex, with All Patients Undergoing COVID 19 Specific Testing. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

THIS IS A PROSPECTIVE OBSERVATIONAL STUDY TO DETERMINE THE ROLE OF PHYSICIAN GESTALT IN CLINICAL PREDICTION OF COVID 19.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Jubilee Mission Medical College and Research Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04974177.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing